Invesco (NYSE:IVZ) First Quarter 2025 Results

Key Financial Results

• Revenue: US$1.53b (up 3.7% from 1Q 2024).
• Net income: US$171.1m (up 21% from 1Q 2024).
• Profit margin: 11% (up from 9.6% in 1Q 2024). The increase in margin was driven by higher revenue.
• EPS: US$0.38 (up from US$0.31 in 1Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Invesco Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is expected to decline by 11% p.a. on average during the next 3 years, while revenues in the Capital Markets industry in the US are expected to grow by 5.2%.

Performance of the American Capital Markets industry.

The company's shares are up 3.5% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Invesco's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.